GCM Brand Values (est.)
Estimated brand valuations in US$. Kroll and IPAM figures as published (IPAM converted at ECB EUR/USD 1.1052, 13 Nov 2026). GCM est. = latest reported annual endorsement, brand or non-touring income × 5, or reported equity in the star’s own brand.
Markets
  • US Dow Jones: 48,816.62 ▼-0.6%
  • US Nasdaq: 23,077.89 ▼-3.4%
  • US S&P 500: 7,032.08 ▼-2.0%
  • Bitcoin: 58,933.00 ▼-6.8%
  • UK FTSE 100: 10,346.34 ▼-1.0%
  • Germany DAX: 24,802.78 ▼-2.6%
  • India Sensex: 83,919.71 ▲+2.3%
  • India Nifty 50: 25,800.60 ▲+2.3%
  • Hong Kong Hang Seng: 22,410.80 ▼-3.8%
  • Japan Nikkei 225: 56,436.65 ▼-5.1%
Live index levels · delayed quotes for reference · not investment advice
BREAKING: Democrats win Senate control in midterm setback for Trump; House projected Democratic (AP call pending)

The Curvy Body Trend in 2026: For Them, for Men, or for the Fee?

curvy body trend: a cream measuring tape coiled around a stack of gold coins on black marble, with a headless ivory blazer form in the background

The curvy body trend is getting two blunt questions in 2026, and they are not the same question. First, why do women still pay for a bigger or more shaped silhouette: is it for them, or to attract men? Second, do bigger busts command premium fees? The clinic numbers and the fashion receipts do not move in lockstep. Self-confidence leads the published surveys. Attraction shows up in the mix. And no public rate card pays a bust-size bonus, even though a handful of curve names did bank a real premium in the last cycle.

The European surgery map, the UK safety rulebook, and the London-to-Paris casting sheet are in the companion piece on EuroCelebs, “Plus-Size Models in Europe 2026: Surgery, Safety, and the Fee Audit.” The figures below are from official society surveys, company-adjacent academic papers, and dated fashion audits. Estimates are labelled. No invented leaks, and no guesses about any named person’s body or medical history.

Measure Latest figure Change Source
Global breast augmentation, 2024 1,658,615 Down 17.5 percent vs 2023 ISAPS Global Survey 2024, released 19 June 2025
Global buttock augmentation, 2024 644,770 Down 21.5 percent vs 2023 Same ISAPS 2024 survey
Global breast implant removal, 2024 341,971 Down 4.4 percent vs 2023 Same ISAPS 2024 survey
Global breast augmentation, 2025 1,622,639 Down 2.2 percent vs 2024 ISAPS Global Survey 2025, released 29 September 2026
Global buttock augmentation, 2025 645,380 Up 0.1 percent vs 2024 Same ISAPS 2025 survey
Global breast implant removal, 2025 360,594 Up 5.4 percent vs 2024 Same ISAPS 2025 survey
Global breast lift, 2025 1,143,862 Up 48.1 percent vs 2024 Same ISAPS 2025 survey
US breast augmentation and implant revision, 2025 304,234 Up 11 percent vs the report’s 2024 baseline of 273,302 ASPS 2025 Procedural Statistics, covered 2 September 2026
US breast implant removals, 2025 45,773 Flat (0 percent) Same ASPS 2025 report
US Brazilian butt lift (fat grafting), 2025 25,662 Down 5 percent Same ASPS 2025 report
ASPS surgeons reporting GLP-1 consultations, 2025 82 percent of member surgeons Consults, not completed operations Same ASPS 2025 member survey

What the curvy body trend looks like in the numbers

The curvy body trend of the 2010s and early 2020s had a nickname in fashion press: the “slim thick” hourglass, often tagged to the Kardashian-era beauty cycle. This newsroom is not assigning surgeries, injections, or weight-loss drugs to any named person. The commercial silhouette is the point. It sold a smaller waist and more shape, and clinics booked the procedures that promised that shape.

Then the volume story cooled. ISAPS, in the 2024 survey released on 19 June 2025, put global breast augmentation at 1,658,615 procedures, down 17.5 percent, and buttock augmentation at 644,770, down 21.5 percent. Breast implant removal was 341,971, a smaller 4.4 percent dip. ISAPS noted a wider respondent base that year, which can affect totals, but those year-over-year drops were reported for procedures tracked consistently.

The 2025 survey, released on 29 September 2026, did not restore the old boom. Global breast augmentation slipped again, to 1,622,639, down 2.2 percent. Buttock augmentation was essentially flat at 645,380, up 0.1 percent. Breast implant removal rose 5.4 percent to 360,594. The jump sat in lifts: breast lift procedures rose 48.1 percent to 1,143,862, the sharpest percentage gain ISAPS flagged among women.

The US ledger, from the American Society of Plastic Surgeons 2025 report, is not a simple copy of the global one. Breast augmentation and implant revision reached 304,234 procedures, up 11 percent against that report’s own 2024 baseline. Breast lifts rose 8 percent to 156,131. Implant removals were flat at 45,773. The Brazilian butt lift, counted as buttock augmentation with fat grafting, fell 5 percent to 25,662, a second act after years of rapid expansion. ASPS also reported a growing preference for “moderate, proportionate implants.” In the member survey that accompanied the report, 82 percent of ASPS Member Surgeons said they received consultation requests related to GLP-1 medications in 2025. The society was careful: consultations are not operations. The lift category still surged, which is what you would expect if rapid weight loss left skin that patients then wanted tightened.

Fashion documented the same swing in a thinner direction. Vogue, on 28 April 2026, reported designers and agents describing a return to smaller runway bodies, and tied that pendulum in part to GLP-1 drugs. The Vogue Business size-inclusivity series is the clean audit. For autumn/winter 2025, published 17 March 2025, plus-size looks (US 14 and up) were 0.3 percent of 8,703 looks across 198 shows. By spring/summer 2027, published 19 October 2026, plus-size looks were 0.5 percent of 9,283 looks across 219 shows. Mid-size plus plus-size, the combined “curve” share, was 2.5 percent, almost half the 5.1 percent recorded for autumn/winter 2025. The curvy body trend did not vanish from clinics or campaigns. It stopped being the default on the catwalk.

For them, or for men?

Ask the question straight, then read the surveys as surveys, not as a sermon. In Aesthetic Surgery Journal Open Forum, on 20 September 2025, William P. Adams Jr. and colleagues published “Drivers and Barriers of Breast Augmentation Surgery: Multinational Insights.” The quantitative arm enrolled 798 women in the United States, the United Kingdom, Brazil, and China. Among 546 who had undergone or considered breast augmentation, the most frequent suggested drivers were to feel more confident (42.3 percent), a sense of deserving satisfaction with their breasts (38.5 percent), and unhappiness with their breasts or body (37.9 percent). Those top reasons were similar across the four countries, with China the exception: “to look sexier” entered the top three there. The paper is useful and it is also sponsored. The authors disclose that the study was funded by MENTOR Worldwide, LLC, a Johnson & Johnson company, and several authors have consultancy or education roles with that manufacturer.

ISAPS itself does not pretend there is only one motive. In the 29 September 2026 press release, Dr Naveen Cavale, chair of the ISAPS communications committee and a plastic surgeon in the UK, listed cosmetics, emotional reasons (self-confidence and wellbeing), social and professional situations including dating, and physical reasons such as back pain from large breasts. ASPS president C. Bob Basu, in the 2025 statistics report, said surgeons overwhelmingly described patients who wanted to look and feel more like themselves after major life changes, including significant weight loss, pregnancy, or aging: “restoration, not transformation.”

So, is the curvy body trend for them or to attract men? The best published patient survey puts self-confidence first. Attraction and dating are on the official list of reasons surgeons hear, and one country arm of the Mentor-funded study elevated “look sexier.” There is no dataset, in this review, that proves a single motive for “women today,” and this newsroom is not going to invent one. People can want a look for themselves and still care how it reads in a room. The receipts say both can be true, with confidence in the lead where percentages exist.

Do bigger busts command premium fees?

Here is the straight answer: there is no public industry rate card that pays a bonus for a bust measurement. Casting and brand desks do not publish a “bigger top, bigger check” menu. Anyone who tells you they have the secret 2026 bust-size tariff is selling a story, not a document.

What does exist is evidence that a small group of curve and plus-size models commanded a real commercial premium at the top of the last cycle, and that the wider booking market has tightened. On 21 November 2017, Forbes listed Ashley Graham as the first curve model on its world’s highest-paid models ranking, at $5.5 million for the year, 10th on the list. Forbes was explicit that the figure was not modeling alone: it included her apparel lines. That is a dated high-water mark, not a 2026 day rate, and it has not been repeated in a later Forbes model-pay ranking that this newsroom could verify.

The more recent money trail sits in reported incomes and in how often plus-size talent is even hired. In Vulture, on 1 January 2026, creator Joanna Spicer said her brand-deal income had fallen by an estimated 50 percent, after a stretch of two or three deals a month collapsed in spring 2024; she declined to share exact rates. The same piece quoted a curve model, speaking only on condition of anonymity, who put her income at $86,240 in 2024 and $45,880 so far in 2025. Those are individual reports, not a market census. They still beat a blank page.

Runway share is the other hard number, and it is not kind to the idea of an expanding premium. Plus-size representation on the big four fashion weeks has stayed under 1 percent in every Vogue Business season cited above, and the combined curve share almost halved between autumn/winter 2025 and spring/summer 2027. A look that is 0.5 percent of the runway is a niche booking, not a category-wide pay boom. The curvy body trend can still mint a star contract. It does not, on the public evidence, automatically mint a bust-size surcharge.

Verdict: agree that some women with a curvier or plus-size profile have commanded premium fees, especially at the peak, with Graham’s 2017 Forbes ranking the clearest audited example. Do not agree that “females with big tops” as a group have a current, documented fee premium tied to bust size. The data does not show that tariff. It shows a fashion cycle that paid a few names handsomely, then booked fewer plus-size looks as the thin pendulum swung back.

For the European operating-room counts, Türkiye travel share, and the UK’s BBL rulebook, read the EuroCelebs fee and safety audit. The talent-fee backdrop for names that still fill a room is the 2026 Celebrity Booking Fees benchmark. Live brand equity is tracked on the Global Celebrity Brand Valuation list. Private wealth context is on Billionaire Meter, and invitation-only hospitality desks sit on Luxury Power Lists. Desks that want a confidential conversation about the next bid can register interest in AI Polymath Bidding before the 24 November 2026 window. VIP world-tour access is routed through Let’s Do It for the Planet on The Global Concert.

FAQ

Did the curvy body trend actually shrink in clinics?

Globally, yes on the “add volume” procedures that defined the last cycle. ISAPS reported a 17.5 percent drop in breast augmentation and a 21.5 percent drop in buttock augmentation in 2024, then a further 2.2 percent dip in breast augmentation in 2025, with buttock augmentation flat. Breast lifts jumped 48.1 percent in 2025, and implant removals rose 5.4 percent. In the US, the ASPS 2025 report showed breast augmentation and implant revision up 11 percent, with surgeons reporting a preference for moderate, proportionate implants, while the Brazilian butt lift fell 5 percent.

Is the motivation self-confidence or attracting a partner?

In the September 2025 Aesthetic Surgery Journal Open Forum study of 798 women in four countries, the leading suggested drivers among those who had undergone or considered breast augmentation were feeling more confident (42.3 percent), deserving satisfaction with their breasts (38.5 percent), and unhappiness with their breasts or body (37.9 percent). The study was funded by MENTOR Worldwide, a Johnson & Johnson company. ISAPS’s Dr Naveen Cavale has also listed dating and other social or professional situations among the reasons patients seek surgery, alongside self-confidence. No survey reviewed here isolates a single motive for all women.

Do bigger busts command premium fees?

There is no public rate card that prices a bust-size bonus. Forbes, on 21 November 2017, put Ashley Graham at $5.5 million and 10th on its highest-paid models list, the first curve model on that ranking, with apparel lines included in the figure. That is a historical high-water mark, not a current tariff. Vogue Business runway audits from 2025 and 2026 show plus-size looks stuck under 1 percent at the big four fashion weeks. Vulture, on 1 January 2026, reported an estimated 50 percent drop in one plus-size creator’s brand-deal income and an anonymous curve model’s fall from $86,240 in 2024 to $45,880 so far in 2025.

Where is the European version of this audit?

The companion piece on EuroCelebs, Plus-Size Models in Europe 2026: Surgery, Safety, and the Fee Audit, covers ISAPS country volumes, medical travel to Türkiye, BAAPS and BAPRAS rules on Brazilian butt lifts, the October 2026 UK government consultation on liquid BBLs, and London, Paris, and Milan casting shares.

Leave a Reply

Your email address will not be published. Required fields are marked *